MedTrace Logo

Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers

NCT03062163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2017-02-23

No results posted yet for this study

Summary

To evaluate the lipolysis effect of resveratrol and lipoic acid transdermal patch in overweight volunteers

Conditions

  • Lipolysis

Interventions

OTHER

Resveratrol lipoic Acid

Transdermal patch loaded with resveratrol and lipoic acid

OTHER

Placebo

Transdermal patch loaded with normal saline

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Amornpun Sereemaspun, MD., Ph.D · Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-23
Primary Completion
2017-02-06
Completion
2017-02-06

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03062163 on ClinicalTrials.gov